国药控股股份有限公司于2026年1月7日发布截至2025年12月31日的股份变动月报表。报告显示，本期公司股本结构保持稳定，未发生新增发行或股份回购等变动。
公司目前拥有H股与内资股两类普通股。截至2025年12月31日，已发行H股1,341,810,740股；内资股1,778,845,451股；合计已发行股份总数3,120,656,191股，与上期相比无增减。报告期内，没有任何股份期权计划或可换股票据的行使、授出、失效情况，也未进行股份购回或注销。
公司确认遵守香港联合交易所有限公司上市规则及相关法律规定。本次公告由公司秘书吴壹建签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.